StockDoc

[StockDoc @XStockDoc]

@KanwalSibal @kanwal @sidhant A transaction should be subjected to the rules of transaction.

[StockDoc @XStockDoc]

@PMOIndia - Legal recourse must be taken against malicious channels with punitive measures including Monetary fines( like Trump), suspension of the journalist’s license and keeping the channel under sanctions.

[CNBC-TV18 @CNBCTV18News]

Our story on government considering tax/cess on foreign travel is not accurate.

We withdraw the story and regret the error.

[StockDoc @XStockDoc]

May be “The Socialist” would suit the name of this magazine.

[The Economist @TheEconomist]

The BJP has beaten a bad ruler in West Bengal. But India must not become a de facto one-party state https://t.co/OtyS0pzBE3

[StockDoc @XStockDoc]

@Chellaney This is a classic example of “Russel Conjugation”

[StockDoc @XStockDoc]

@TheEconomist @TheEconomist - What kind of Media Masturbation is this?

[StockDoc @XStockDoc]

Burger ate the CEO

[StockDoc @XStockDoc]

This is an entirely different playing field. There isn’t going to be any competition between an oral weight loss pill vs an injectable one!
$NVO 🚀

[StockDoc @XStockDoc]

$NVO launched Wegovy oral pill!

It is a paradigm shift in weight loss management similar to when GLP-1 was introduced.

There is no competition between an oral pill that doesn’t need special storage vs a peptide injection that has specific storage requirements and of course injecting oneself.

This is an entirely new category. It opens up entirely new possibilities.

[StockDoc @XStockDoc]

$NVO launched Wegovy oral pill!

It is a paradigm shift in weight loss management similar to when GLP-1 was introduced.

There is no competition between an oral pill that doesn’t need special storage vs a peptide injection that has specific storage requirements and of course injecting oneself.

This is an entirely new category. It opens up entirely new possibilities.

[Eric Nelson, CFA @ServoWealth]

This investing stat never ceases to blow my mind! 😳😳😳

How much can a diversified equity portfolio help you in retirement?

If you had $1M in 2000, needing $50k/yr plus inflation—

You WERE BROKE BY 2016 if you invested 100% in S&P 500!

If you instead invested in a (globally) diversified stock portfolio (with small cap & value exposure), you had $3.0M left—3x your starting amount!—in 2025, including almost $800k more annual spending from 2017-2025!

Share this with EVERY retired or soon-to-be retired person you know!

[StockDoc @XStockDoc]

@DerrickEvans4WV @Grok explain how to make this type of chart without actually coding?

[StockDoc @XStockDoc]

Great, Good and Gruesome!

3 types of businesses according to Warren Buffet.

He wrote about this In Berkshire Hathaway’s 2007 shareholders letters.

[StockDoc @XStockDoc]

Gruesome Businesses: These businesses grow rapidly and consume huge amounts of capital but earn little or no money, or returns that do not justify the investment.
•Analogy: A "gruesome" savings account that pays an inadequate interest rate and requires you to continuously add money at those disappointing returns.
•Example: The airline industry, which Buffett famously described as a "bottomless pit" for capital, where growth attracts investors even though the economics are poor and even good management cannot overcome the industry's fundamental challenges.

[StockDoc @XStockDoc]

The Thanksgiving Turkey: A lesson in Risk.

This story illustrates the Black Swan problem: the limits of knowledge, the danger of using past data to predict extreme future events, and the problem of "fooled by randomness".

999 good days for the Turkey ends with one catastrophic fatality!

Happy Thanksgiving!

[StockDoc @XStockDoc]

Hey, @grok, who were 10
most famous persons to visit my profile? It doesn't need to be a mutual, don't tag them, just say who it was

[StockDoc @XStockDoc]

When the market leader and the indices sell off after a good earnings report, time to pack and go hiking!

[StockDoc @XStockDoc]

EVOKE/EVOKE+ trials will be pivotal for Novo Nordisk. Probability of validating an entirely new therapeutic paradigm in Alzheimer's disease. The risk/reward profile is asymmetric - $NVO trades at 12-13x PE.